Elekta (OTCMKTS:EKTAY) Sees Large Volume Increase – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) saw strong trading volume on Tuesday . 6,183 shares changed hands during mid-day trading, an increase of 106% from the previous session’s volume of 3,007 shares.The stock last traded at $5.1249 and had previously closed at $5.0490.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Reduce”.

Elekta Trading Down 0.5%

The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47. The firm has a market cap of $1.89 billion, a PE ratio of -32.00 and a beta of 1.01. The company has a 50-day simple moving average of $5.18 and a 200 day simple moving average of $5.81.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The firm had revenue of $521.00 million for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. As a group, sell-side analysts forecast that Elekta AB will post 0.43 earnings per share for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.